Tag
Gufic Biosciences Limited
4 articles
Gufic Biosciences Q1 FY27 Earnings Call Recording
Gufic Biosciences submitted audio recording of its Q1 FY27 earnings conference call held on August 17, 2026 to BSE and NSE.
The recording was uploaded to company website pursuant to SEBI Listing Regul
Gufic Biosciences Q1 FY27 Revenue Rises 15% YoY
Gufic Biosciences reported Q1 FY27 revenue of ₹260.8 crore, a 15% YoY increase, with EBITDA margin expanding to 18.09%.
The company's new Indore injectable facility achieved commercial production, tar
Gufic Biosciences Philippines Subsidiary Incorporation Approved
Gufic Biosciences board approved incorporation of a Philippines subsidiary for marketing and distribution.
Investment of up to USD 250,000 for 99.99% stake in the new pharmaceutical subsidiary.
Subsid
Gufic Biosciences Q1 FY27 Net Profit Rises 86% YoY
Gufic Biosciences approved unaudited Q1 FY27 standalone net profit of ₹22.46 crore, an 86% increase from Q1 FY26.
Consolidated revenue for the quarter stood at ₹260.82 crore, with a net profit of ₹22.